questionsmedicales.fr
Phénomènes génétiques
Régulation de l'expression des gènes
Modification traductionnelle des protéines
Maturation post-traductionnelle des protéines
Réponse aux protéines mal repliées
Réponse aux protéines mal repliées : Questions médicales fréquentes
Termes MeSH sélectionnés :
Gene Expression Profiling
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Réponse aux protéines mal repliées : Questions médicales les plus fréquentes",
"headline": "Réponse aux protéines mal repliées : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Réponse aux protéines mal repliées : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-01-14",
"dateModified": "2025-04-08",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Réponse aux protéines mal repliées"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Maturation post-traductionnelle des protéines",
"url": "https://questionsmedicales.fr/mesh/D011499",
"about": {
"@type": "MedicalCondition",
"name": "Maturation post-traductionnelle des protéines",
"code": {
"@type": "MedicalCode",
"code": "D011499",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "G05.308.670.600"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Dégradation associée au réticulum endoplasmique",
"alternateName": "Endoplasmic Reticulum-Associated Degradation",
"url": "https://questionsmedicales.fr/mesh/D060746",
"about": {
"@type": "MedicalCondition",
"name": "Dégradation associée au réticulum endoplasmique",
"code": {
"@type": "MedicalCode",
"code": "D060746",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "G05.308.670.600.850.500"
}
}
}
],
"about": {
"@type": "MedicalCondition",
"name": "Réponse aux protéines mal repliées",
"alternateName": "Unfolded Protein Response",
"code": {
"@type": "MedicalCode",
"code": "D056811",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Nektarios Barabutis",
"url": "https://questionsmedicales.fr/author/Nektarios%20Barabutis",
"affiliation": {
"@type": "Organization",
"name": "School of Basic Pharmaceutical and Toxicological Sciences, College of Pharmacy, University of Louisiana Monroe, Monroe, LA, USA."
}
},
{
"@type": "Person",
"name": "Khadeja-Tul Kubra",
"url": "https://questionsmedicales.fr/author/Khadeja-Tul%20Kubra",
"affiliation": {
"@type": "Organization",
"name": "School of Basic Pharmaceutical and Toxicological Sciences, College of Pharmacy, University of Louisiana Monroe, Monroe, LA 71201, USA."
}
},
{
"@type": "Person",
"name": "Federica Brandizzi",
"url": "https://questionsmedicales.fr/author/Federica%20Brandizzi",
"affiliation": {
"@type": "Organization",
"name": "MSU-DOE Plant Research Lab and Plant Biology Department Michigan State University, East Lansing, MI, USA. fb@msu.edu."
}
},
{
"@type": "Person",
"name": "Wensheng Lin",
"url": "https://questionsmedicales.fr/author/Wensheng%20Lin",
"affiliation": {
"@type": "Organization",
"name": "Department of Neuroscience; Institute for Translational Neuroscience, University of Minnesota, Minneapolis, MN, USA."
}
},
{
"@type": "Person",
"name": "Mohammad S Akhter",
"url": "https://questionsmedicales.fr/author/Mohammad%20S%20Akhter",
"affiliation": {
"@type": "Organization",
"name": "School of Basic Pharmaceutical and Toxicological Sciences, College of Pharmacy, University of Louisiana Monroe, Monroe, LA 71201, USA."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Genome-wide identification and expression profiling of sugar transporter genes in tobacco.",
"datePublished": "2022-06-14",
"url": "https://questionsmedicales.fr/article/35714802",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.gene.2022.146652"
}
},
{
"@type": "ScholarlyArticle",
"name": "Gene expression profiling of pancreatic ductal adenocarcinomas in response to neoadjuvant chemotherapy.",
"datePublished": "2023-08-02",
"url": "https://questionsmedicales.fr/article/37533202",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1002/cam4.6411"
}
},
{
"@type": "ScholarlyArticle",
"name": "The NeuroinflammatoryPotential of HIV-1 NefVariants in Modulating the Gene Expression Profile of Astrocytes.",
"datePublished": "2022-10-17",
"url": "https://questionsmedicales.fr/article/36291123",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3390/cells11203256"
}
},
{
"@type": "ScholarlyArticle",
"name": "Gene expression profiling of Group 3 medulloblastomas defines a clinically tractable stratification based on KIRREL2 expression.",
"datePublished": "2022-06-30",
"url": "https://questionsmedicales.fr/article/35771282",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s00401-022-02460-1"
}
},
{
"@type": "ScholarlyArticle",
"name": "Genes deregulated in giant cell arteritis by Nanostring nCounter gene expression profiling in temporal artery biopsies.",
"datePublished": "2024-09-24",
"url": "https://questionsmedicales.fr/article/39317454",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1136/rmdopen-2024-004600"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Phénomènes génétiques",
"item": "https://questionsmedicales.fr/mesh/D055614"
},
{
"@type": "ListItem",
"position": 3,
"name": "Régulation de l'expression des gènes",
"item": "https://questionsmedicales.fr/mesh/D005786"
},
{
"@type": "ListItem",
"position": 4,
"name": "Modification traductionnelle des protéines",
"item": "https://questionsmedicales.fr/mesh/D046188"
},
{
"@type": "ListItem",
"position": 5,
"name": "Maturation post-traductionnelle des protéines",
"item": "https://questionsmedicales.fr/mesh/D011499"
},
{
"@type": "ListItem",
"position": 6,
"name": "Réponse aux protéines mal repliées",
"item": "https://questionsmedicales.fr/mesh/D056811"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Réponse aux protéines mal repliées - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Réponse aux protéines mal repliées",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-12",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Réponse aux protéines mal repliées",
"description": "Comment diagnostiquer une UPR ?\nQuels tests sont utilisés pour l'UPR ?\nL'imagerie est-elle utile pour l'UPR ?\nQuels biomarqueurs indiquent l'UPR ?\nL'historique médical aide-t-il au diagnostic ?",
"url": "https://questionsmedicales.fr/mesh/D056811?mesh_terms=Gene+Expression+Profiling&page=3#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Réponse aux protéines mal repliées",
"description": "Quels sont les symptômes de l'UPR ?\nL'UPR cause-t-elle des douleurs ?\nY a-t-il des symptômes neurologiques ?\nL'UPR affecte-t-elle le métabolisme ?\nDes symptômes digestifs sont-ils possibles ?",
"url": "https://questionsmedicales.fr/mesh/D056811?mesh_terms=Gene+Expression+Profiling&page=3#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Réponse aux protéines mal repliées",
"description": "Comment prévenir l'UPR ?\nL'évitement de toxines est-il important ?\nLes bilans de santé réguliers sont-ils utiles ?\nL'éducation sur l'UPR est-elle nécessaire ?\nLe soutien psychologique aide-t-il ?",
"url": "https://questionsmedicales.fr/mesh/D056811?mesh_terms=Gene+Expression+Profiling&page=3#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Réponse aux protéines mal repliées",
"description": "Quels traitements existent pour l'UPR ?\nL'alimentation influence-t-elle l'UPR ?\nLes exercices physiques sont-ils bénéfiques ?\nDes médicaments spécifiques sont-ils prescrits ?\nLa thérapie génique est-elle une option ?",
"url": "https://questionsmedicales.fr/mesh/D056811?mesh_terms=Gene+Expression+Profiling&page=3#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Réponse aux protéines mal repliées",
"description": "Quelles complications peuvent survenir ?\nL'UPR peut-elle entraîner des maladies chroniques ?\nY a-t-il un risque accru de cancer ?\nDes troubles cardiovasculaires sont-ils possibles ?\nL'UPR affecte-t-elle la longévité ?",
"url": "https://questionsmedicales.fr/mesh/D056811?mesh_terms=Gene+Expression+Profiling&page=3#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Réponse aux protéines mal repliées",
"description": "Quels sont les facteurs de risque de l'UPR ?\nL'âge est-il un facteur de risque ?\nLe mode de vie influence-t-il l'UPR ?\nLes maladies auto-immunes sont-elles un risque ?\nLe tabagisme est-il un facteur de risque ?",
"url": "https://questionsmedicales.fr/mesh/D056811?mesh_terms=Gene+Expression+Profiling&page=3#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une UPR ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic repose sur des tests génétiques et des marqueurs de stress cellulaire."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour l'UPR ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des analyses de protéines et des biopsies tissulaires peuvent être effectuées."
}
},
{
"@type": "Question",
"name": "L'imagerie est-elle utile pour l'UPR ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'imagerie n'est pas spécifique, mais peut aider à évaluer des complications."
}
},
{
"@type": "Question",
"name": "Quels biomarqueurs indiquent l'UPR ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des protéines comme la CHOP et la GRP78 sont des biomarqueurs de l'UPR."
}
},
{
"@type": "Question",
"name": "L'historique médical aide-t-il au diagnostic ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'historique de maladies métaboliques ou génétiques est pertinent."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes de l'UPR ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent fatigue, douleurs musculaires et troubles métaboliques."
}
},
{
"@type": "Question",
"name": "L'UPR cause-t-elle des douleurs ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des douleurs musculaires et articulaires peuvent survenir."
}
},
{
"@type": "Question",
"name": "Y a-t-il des symptômes neurologiques ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des troubles cognitifs et des maux de tête peuvent être présents."
}
},
{
"@type": "Question",
"name": "L'UPR affecte-t-elle le métabolisme ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elle peut entraîner des déséquilibres métaboliques et de la résistance à l'insuline."
}
},
{
"@type": "Question",
"name": "Des symptômes digestifs sont-ils possibles ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des nausées et des troubles gastro-intestinaux peuvent se manifester."
}
},
{
"@type": "Question",
"name": "Comment prévenir l'UPR ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Maintenir un mode de vie sain et gérer le stress peut aider à prévenir l'UPR."
}
},
{
"@type": "Question",
"name": "L'évitement de toxines est-il important ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, éviter les toxines environnementales peut réduire le risque d'UPR."
}
},
{
"@type": "Question",
"name": "Les bilans de santé réguliers sont-ils utiles ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des bilans réguliers peuvent détecter des problèmes précoces liés à l'UPR."
}
},
{
"@type": "Question",
"name": "L'éducation sur l'UPR est-elle nécessaire ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, sensibiliser les patients et les professionnels est crucial pour la prévention."
}
},
{
"@type": "Question",
"name": "Le soutien psychologique aide-t-il ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le soutien psychologique peut réduire le stress et améliorer la santé globale."
}
},
{
"@type": "Question",
"name": "Quels traitements existent pour l'UPR ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements incluent des thérapies ciblées et des médicaments anti-inflammatoires."
}
},
{
"@type": "Question",
"name": "L'alimentation influence-t-elle l'UPR ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une alimentation riche en antioxydants peut aider à réduire le stress cellulaire."
}
},
{
"@type": "Question",
"name": "Les exercices physiques sont-ils bénéfiques ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'exercice modéré peut améliorer la réponse au stress cellulaire."
}
},
{
"@type": "Question",
"name": "Des médicaments spécifiques sont-ils prescrits ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des médicaments comme les inhibiteurs de la protéase peuvent être utilisés."
}
},
{
"@type": "Question",
"name": "La thérapie génique est-elle une option ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "La thérapie génique est en recherche pour corriger des défauts liés à l'UPR."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des maladies métaboliques, des troubles neurologiques et des cancers peuvent survenir."
}
},
{
"@type": "Question",
"name": "L'UPR peut-elle entraîner des maladies chroniques ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'UPR est liée à des maladies chroniques comme le diabète et l'obésité."
}
},
{
"@type": "Question",
"name": "Y a-t-il un risque accru de cancer ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'UPR est associée à un risque accru de certains types de cancer."
}
},
{
"@type": "Question",
"name": "Des troubles cardiovasculaires sont-ils possibles ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'UPR peut contribuer à des troubles cardiovasculaires et à l'inflammation."
}
},
{
"@type": "Question",
"name": "L'UPR affecte-t-elle la longévité ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des études suggèrent que l'UPR peut influencer la longévité et la santé globale."
}
},
{
"@type": "Question",
"name": "Quels sont les facteurs de risque de l'UPR ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent le stress oxydatif, l'inflammation et des prédispositions génétiques."
}
},
{
"@type": "Question",
"name": "L'âge est-il un facteur de risque ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le vieillissement augmente le risque de dysfonctionnement de l'UPR."
}
},
{
"@type": "Question",
"name": "Le mode de vie influence-t-il l'UPR ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un mode de vie sédentaire et une mauvaise alimentation augmentent le risque."
}
},
{
"@type": "Question",
"name": "Les maladies auto-immunes sont-elles un risque ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les maladies auto-immunes peuvent exacerber la réponse aux protéines mal repliées."
}
},
{
"@type": "Question",
"name": "Le tabagisme est-il un facteur de risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le tabagisme est lié à un stress cellulaire accru et à l'UPR."
}
}
]
}
]
}
Sugars are both nutrients and important signal molecules in higher plants. Sugar transporters (STs) are involved in sugar loading and unloading and facilitate sugar transport across membranes. Tobacco...
Pancreatic ductal adenocarcinoma (PDAC) has the lowest survival rate of all major cancers. Chemotherapy is the mainstay systemic therapy for PDAC, and chemoresistance is a major clinical problem leadi...
Archived formalin-fixed paraffin-embedded tumor tissue samples from patients treated with neoadjuvant chemotherapy were obtained during surgical resection. Specimens were macrodissected and gene expre...
Initially, unsupervised multivariate modeling was performed by principal component analysis, which demonstrated a distinct gene expression profile between good- and poor-chemotherapy responders. There...
A distinct tumor biological profile between PDAC patients who either respond or not respond to chemotherapy was identified....
HIV-1 mediated neurotoxicity is thought to be associated with HIV-1 viral proteins activating astrocytes and microglia by inducing inflammatory cytokines leading to the development of HIV-associated n...
Medulloblastomas (MB) molecularly designated as Group 3 (Grp 3) MB represent a more clinically aggressive tumor variant which, as a group, displays heterogeneous molecular characteristics and disease ...
To identify differentially expressed genes in temporal artery biopsies (TABs) from patients with giant cell arteritis (GCA) with different histological patterns of inflammation: transmural inflammatio...
Expression of 770 immune-related genes was profiled with the NanoString nCounter PanCancer Immune Profiling Panel on formalin-fixed paraffin-embedded TABs from 42 GCA patients with TMI, 7 GCA patients...
Unsupervised clustering of the samples revealed two distinct groups: normal TABs and TABs with ILA in one group, 41/42 TABs with TMI in the other one. TABs with TMI showed 31 downregulated and 256 upr...
TABs with TMI had a distinct transcriptome compared with normal TABs and TABs with ILA. The few genes potentially deregulated in ILA were also deregulated in TMI. Gene profiling allowed to deepen the ...
Esophageal squamous cell carcinoma (ESCC) is one of the subtypes of esophageal cancer with Chinese characteristics, and its five-year survival rate is less than 20%. Early diagnosis is beneficial to i...
To investigate the relationship between primary ovarian insufficiency and autophagy, we detected and got the expression profile of human granulosa cell line SVOG, which was with or without LPS induced...
Totally, 6 genes were selected as candidate hub genes which might correlate with the process of primary ovarian insufficiency. The expression of hub genes was then validated by quantitative real-time ...
The results indicated that autophagy might play an essential role in the process and underlying molecular mechanism of primary ovarian insufficiency, which was revealed for the first time and may help...
The JAK-STAT signaling pathway is a central cascade of signal transduction for the myriad of cytokines in which dysregulation has been implicated in progression of inflammatory and infectious diseases...
This study sought to investigate differential gene expression of several cytokines and their associated...
Results showed that the gene expression levelsof both Th1 (...
Our finding revealed dysregulation of cytokines and related...
Gonadotrophic pituitary adenoma is a major subtype of pituitary adenoma in the sellar region, but it is rarely involved in the hypersecretion of hormones into blood; thus, it is commonly regarded as "...
The hPASCs from 14 human gonadotrophic pituitary adenoma clinical samples were cultured and verified via immunohistochemistry. Genetic profiling of hPASCs and the matched tumor cells was performed thr...
The hPASCs were successfully isolated and cultured from gonadotrophic pituitary adenoma in vitro, which were identified as positive for generic stem cell markers (Sox2, Oct4, Nestin and CD133) via imm...
Genetic profiling of hPASCs may explain the tumorigenesis and invasiveness of gonadotrophic pituitary adenoma. ANXA2 may serve as a potential therapeutic target for the treatment of gonadotrophic pitu...
Using petiole material as explants and directly inducing the formation of microtubers without going through the callus stage is an essential way to rapidly expand scarce medical plants such as...